MSMary E. Soyster

Mary E. Soyster

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mary E. Soyster has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Jason L. Zappia

    Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

    2 shared publications
  • Joshua D. Roth

    Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

    2 shared publications
  • M. Francesca Monn

    Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA

    2 shared publications
  • Matthew J. Mellon

    Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

    2 shared publications
  • Peter J. Arnold

    Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

    2 shared publications
  • Ramzy T. Burns

    Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

    2 shared publications

Latest Publications

  • Long-term Renal Preservation and Complication Profile With Ileal Ureter Creation

    by Mary E. Soyster, Ramzy T. Burns, James E. Slaven, Jason L. Zappia, Peter J. Arnold, Joshua D. Roth, Richard Bihrle, M. Francesca Monn, Matthew J. Mellon


  • AUTHOR REPLY

    by Mary Soyster

  • Ileal Ureter Utilization in Patients With Previous Urinary Diversions

    by Mary E. Soyster, Peter J. Arnold, Ramzy T. Burns, Jason L. Zappia, Joshua D. Roth, M. Francesca Monn, Richard Bihrle, Matthew J. Mellon


  • Impact of American Society of Anesthesiologists score on postoperative holmium enucleation of the prostate outcomes and complications

    by Mary E. Soyster, Deepak Agarwal, Austen Slade, Erica Sahm, Tim Large, Marcelino Rivera

    Introductions: The American Society of Anesthesiologists Physical Status Classification System (ASA) is a validated risk stratification method for patients undergoing surgery. There is an increased prevalence of benign prostatic hyperplasia and comorbidities in our aging population. The role of ASA related to postoperative complications in patients undergoing holmium laser enucleation of the prostate (HoLEP) has not been described.Methods: A review of our database was performed for patients who underwent HoLEP from July 2018 to December 2020. Patients were stratified based on ASA score. Preoperative, perioperative, and complication data were analyzed using SAS analytics software.Results: Of 472 patients undergoing HoLEP, 320 (67.8%) were ASA 3–4 patients. There was a statistically significant difference found in age (72.3 ± 9.8 vs. 69.1 ± 9.0 years, p < 0.001), body mass index (BMI) (29.0 ± 5.9 vs. 27.3 ± 4.2, p = 0.004), and use of antiplatelet/anticoagulant medications (14.6% vs. 2.6%, p < 0.001) in the ASA 3–4 group. There was no significant difference between prostate volume (p = 0.158) or catheter‐dependent urinary retention (p = 0.376). No difference was found in enucleation time (52.76 ± 24.8 vs. 54.16 ± 23.7 min, p = 0.587), OR specimen weight (70.24 ± 58.5 vs. 81.53 ± 65.9, p = 0.094). or intraoperative complications (2.8% vs. 1.3%, p = 0.330). There were higher postoperative complications in the ASA 3–4 group (12.8% vs. 7.9%, p = 0.03), but no difference in Clavien ≥3 complications (p = 0.068). ASA 3–4 patients had similar postoperative international prostate symptom score (p = 0.159).Conclusion: HoLEP is feasible and effective in patients who are ASA 3–4. The high‐risk cohort had an increased rate of low‐grade complications. Patients with an ASA score of 3–4 should be counseled regarding a higher rate of low‐grade complications.


  • Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared with Mesh

    by Megan E. Bock, Ramzy T Nagle, Mary Soyster, Leo Song, Isamu Tachibana, Jon K. Hathaway, Charles R. Powell

    Objective The objective is to compare robotic sacral colpopexy (RSC) utilizing autologous fascia lata to RSC with synthetic mesh in the treatment of pelvic organ prolapse. Methods We performed a prospective non-randomized case comparison trial at a single institution. We compared RSC utilizing either synthetic mesh or autologous fascia lata in women with symptomatic pelvic organ prolapse, stages II through IV. The primary outcome was anatomic prolapse recurrence determined by the Pelvic Organ Prolapse Quantification (POP-Q) exam. Secondary outcomes included patient reported outcomes such as the Urogenital Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7). Complications were also recorded and categorized using the Clavien-Dindo system (CD). The hypothesis is that autologous fascia lata would provide equivalent anatomic and patient reported outcomes compared to mesh while eliminating mesh related complications. Results Sixty-four women underwent RSC with 19 (29.7%) receiving fascia lata graft. The overall operative time was greater in the fascia lata group with mean fascia lata harvest time of 24.8±7.4 minutes. Intragroup comparisons of the fascia and mesh groups demonstrated significant improvement in pelvic measurements as well as patient reported outcomes. Intergroup comparison demonstrated equivalent success rates at 12.1±8.7 months follow up. There was one apical failure in the fascia lata RSC group, however the difference was not statistically significant (p=0.30). Significant complications in the fascia lata harvest group included two CD-II and one CD-IIIb. In the mesh group there was one mesh erosion requiring surgical excision (CD-IIIb). Conclusion This is the first comparison between RSC with autologous fascia lata vs. mesh. Short-term anatomic outcomes were similar with autologous fascia lata use without the risk of mesh erosion. Morbidity from graft harvest site was not trivial. These results emphasize the need for a randomized controlled trial.